Is it safe to discontinue insulin in an elderly patient with dementia who is experiencing episodes of loss of consciousness, uncertain insulin adherence, possibly inadequate food intake, and an HbA1c of 6.8%?

Discontinuing Insulin in This Patient is Appropriate and Likely Necessary

Yes, stopping insulin in this elderly patient with dementia, recurrent episodes of loss of consciousness, uncertain medication adherence, questionable food intake, and an HbA1c of 6.8% is not only safe but clinically indicated to prevent life-threatening hypoglycemia. The HbA1c of 6.8% suggests she may already be experiencing overtreatment, and continuing insulin in this context poses significant mortality risk.

Why Insulin Should Be Stopped

Immediate Safety Concerns

This patient meets multiple high-risk criteria that mandate treatment de-intensification 1:

• Cognitive impairment/dementia - Creates inability to recognize hypoglycemia symptoms, manage insulin dosing, or coordinate meals with insulin timing
• Recurrent loss of consciousness - Strongly suggests severe hypoglycemia (Level 3 hypoglycemia requiring assistance)
• Uncertain medication adherence - Risk of accidental overdosing or erratic insulin administration
• Questionable food intake - Insulin without adequate carbohydrate intake is a recipe for severe hypoglycemia

The bidirectional relationship between hypoglycemia and dementia is critical here: severe hypoglycemia worsens cognitive decline, and cognitive impairment increases hypoglycemia risk 1, 2. You're dealing with a dangerous cycle that must be broken.

The HbA1c of 6.8% Confirms Overtreatment

For an elderly patient with dementia and functional impairment, an HbA1c of 6.8% is too low and indicates intensive glycemic control that is inappropriate for her risk profile 1, 3, 4:

• Recommended HbA1c target for patients with cognitive impairment and functional dependence: 8.0-8.5% 1, 5
• Her current HbA1c suggests she's being treated to standards appropriate for healthy younger adults, not frail elderly with dementia
• Studies show no benefit from intensive control (HbA1c <7%) in older adults with multiple comorbidities, but consistent harm from hypoglycemia 6

An observational study of nursing home patients with HbA1c ≤6.0% found that 75% remained stable 3 months after complete withdrawal of diabetes medications, with mean HbA1c rising only to 5.8% 7. Your patient's HbA1c of 6.8% suggests similar safety for discontinuation.

What to Do Instead

Immediate Actions

1. Stop all insulin immediately - The passing out episodes are medical emergencies that will recur if insulin continues 8, 9
2. Discontinue any sulfonylureas or meglitinides if she's taking them - These also cause hypoglycemia 2, 10
3. Educate caregivers about hypoglycemia symptoms and ensure glucagon is available during the transition 8, 9

Monitoring During Transition

• Check blood glucose 2-3 times daily for the first week, then adjust frequency based on stability
• Monitor for hyperglycemic symptoms (polyuria, polydipsia, weight loss)
• Recheck HbA1c in 3 months 3

Long-term Management Options

If HbA1c remains <8.0% after insulin discontinuation:

• Continue without diabetes medications
• Focus on dietary management appropriate to her preferences and abilities 4

If HbA1c rises to 8.0-8.5%:

• This is the target range for her risk category - no treatment needed 1, 5

If HbA1c rises above 8.5-9.0%:

• Consider metformin only if tolerated - it has protective effects and minimal hypoglycemia risk 2, 11
• Alternatively, consider GLP-1 receptor agonists if appropriate (low hypoglycemia risk, potential cognitive benefits) 2
• Avoid insulin, sulfonylureas, and meglitinides given her risk profile 2, 10

Critical Pitfalls to Avoid

Do not restart insulin "just to be safe" - The evidence is clear that intensive glycemic control in this population causes harm without benefit 1, 6. The passing out episodes are the harm manifesting.

Do not aim for HbA1c <7.5% - This target is only appropriate for healthy older adults with intact cognition and function 1, 5. Your patient does not meet these criteria.

Do not assume she needs diabetes medications at all - With an HbA1c of 6.8%, she may have been overtreated for years. Research shows that 31.5% of high-risk patients receiving insulin or sulfonylureas have HbA1c <7.0%, representing potential overtreatment 12.

The Evidence Supporting This Decision

The most recent ADA guidelines (2022-2025) explicitly state that hypoglycemia should be avoided in older adults with diabetes and should be managed by adjusting glycemic targets and pharmacologic regimens 1, 4, 2, 13. When patients experience severe hypoglycemia (your patient's loss of consciousness), guidelines mandate raising glycemic targets and reevaluating the treatment regimen 8, 9.

Older adults aged 80+ are 5 times more likely to be hospitalized for insulin-related hypoglycemia than those aged 45-64 14. The mortality risk from severe hypoglycemia in this population far exceeds any theoretical benefit from tight glycemic control.

Your clinical instinct to stop insulin was correct. The HbA1c of 6.8% confirms she doesn't need it, and her clinical presentation demands its discontinuation.